NIH-funded research R01 grant

How heme affects immune cell development and inflammation

Official title: Ligand-dependent regulation of the nuclear receptor REV-ERBa in TH17 cell development and inflammation

Funded at University of Florida · NIH-11005026 · Data updated 2026-11-12

This study is looking at how a natural molecule called heme affects certain immune cells that play a role in inflammation, especially in conditions like colitis, to help us understand how diet and the environment might influence gut health and improve treatment options for inflammatory diseases.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startMarch 1, 2023
Project endDecember 31, 2026
Funding year2025
Award (this year)$592,971
NIH project number5R01DK135300-03
Project IDNIH-11005026 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from inflammatory bowel diseases, particularly those with colitis.

Less likely to help

Patients without inflammatory conditions or those not affected by TH17 cell-related inflammation may not benefit from this research.

What this research studies

This research investigates the role of heme, a natural molecule, in regulating immune cells known as TH17 cells, which are involved in inflammation and conditions like colitis. By understanding how heme influences the activity of a specific protein called REV-ERBa, the researchers aim to uncover the mechanisms that control inflammation in the gut. The study will explore both the sources of heme and its effects on immune responses, potentially leading to new insights into how dietary factors and environmental signals impact health. Patients may benefit from findings that could lead to better management of inflammatory diseases.

Why it matters

Potential benefit: If successful, this research could provide new strategies for treating inflammatory conditions like colitis.

How similar studies have gone: Previous research has shown promising results in understanding the role of ligands in immune regulation, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Solt, Laura a — University of Florida
  • Study coordinator: Solt, Laura a

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.